|
- New USPSTF Recommendation on Aspirin in CVD: No For Primary Prevention . . .
In adults ages 40 to 59 years, the updated recommendations on the use of aspirin in the setting of the primary prevention of ASCVD, published in JAMA, call for individualizing low-dose aspirin therapy for those who have a 10% or greater 10-year cardiovascular disease risk
- Daily aspirin therapy: Understand the benefits and risks
Daily aspirin therapy may be used in two ways: Primary prevention This means that you've never had a heart attack or stroke You've never had coronary bypass surgery or coronary angioplasty with stent placement You've never had blocked arteries in your neck, legs or other parts of the body
- Aspirin for the Primary Prevention of Cardiovascular Disease: Time for . . .
The USPSTF recommends the following: (1) low-dose aspirin should not be initiated for primary prevention in individuals ages 60 years or older, and (2) initiation of low-dose aspirin should be considered on an individualized basis in adults aged 40 to 59 years with a 10-year CVD risk of ≥10% 1 With the update, the USPSTF no longer recommends
- Aspirin in the primary prevention of cardiovascular disease . . . - UpToDate
Aspirin produces important reductions in CVD morbidity and mortality among survivors of a wide range of occlusive CVD events, especially myocardial infarction and stroke In secondary prevention, the absolute benefits on occlusive events are far greater than the absolute risks of major bleeding
- Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication
For patients initiating aspirin use, it would be reasonable to use a dose of 81 mg day For adults 60 years or older: Do not initiate aspirin for primary prevention of CVD What additional information should clinicians know about this recommendation? Age is one of the strongest risk factors for CVD
- New USPSTF guidance: Continue to take low-dose aspirin if you have a . . .
The scientific evidence continues to confirm healthy lifestyle habits and effectively managing blood pressure and cholesterol are the top ways to prevent a first heart attack or stroke, not low-dose aspirin The new USPSTF guidance now aligns with American Heart Association’s 2019 primary prevention guideline
- Aspirin for primary prevention of cardiovascular disease: What do the . . .
The 2022 US Preventive Services Task Force (USPSTF) recommendation notes that the decision to initiate daily aspirin therapy for primary prevention of cardiovascular disease (CVD) should be made on a case-by-case basis for adults ages 40 to 59 with a 10% or greater 10-year CVD risk
- Aspirin Therapy: When to Initiate, When to Maintain - MedCentral
These guidelines recommend against initiation of low-dose aspirin for ASCVD prevention in those over age 60 but for the use of aspirin to prevent a second cardiovascular event in high-risk patients – that is, those who have had a previous heart attack or stroke
|
|
|